We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
+12.8%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.21B
AUM Growth
-$296M
(-8.4%)
Cap. Flow
-$592M
Cap. Flow
% of AUM
-18.42%
Top 10 Holdings %
Top 10 Hldgs %
43.24%
Holding
304
New
89
Increased
36
Reduced
82
Closed
88
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AtaiBeckley Inc
ATAI
|
+$25.3M |
| 2 |
Agilon Health
AGL
|
+$13.5M |
| 3 |
Eli Lilly
LLY
|
+$13.2M |
| 4 |
Privia Health
PRVA
|
+$12.8M |
| 5 |
Lantheus
LNTH
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$23.9M |
| 2 |
Vericel Corp
VCEL
|
+$20.8M |
| 3 |
Align Technology
ALGN
|
+$19M |
| 4 |
SI-BONE Inc
SIBN
|
+$17.5M |
| 5 |
STAAR Surgical
STAA
|
+$14.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.64% |
| 2 | Industrials | 1.41% |
| 3 | Materials | 0.54% |
| 4 | Financials | 0.48% |
| 5 | Consumer Staples | 0.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVAC
76
CALL
DELISTED
CureVac
CVAC
| $9.72M | 0.3% |
+132,300
| New | +$13.2M |
|
77
Bioventus
BVS
$1.16B
| $9.58M | 0.3% |
544,545
-332,517
| -38% | -$5.36M |
|
78
PUT
Zoetis
ZTS
$31.1B
| $9.32M | 0.29% |
+50,000
| New | +$8.68M |
|
|
CVAC
79
PUT
DELISTED
CureVac
CVAC
| $9.31M | 0.29% |
+126,700
| New | +$12.7M |
|
80
iRhythm Holdings
IRTC
$4.02B
| $9.29M | 0.29% |
+140,000
| New | +$11.1M |
|
81
PUT
Fulgent Genetics
FLGT
$523M
| $9.22M | 0.29% |
100,000
-10,000
| -9% | -$798K |
|
|
XENT
82
DELISTED
Intersect ENT, Inc
XENT
| $9.08M | 0.28% |
531,229
-378,431
| -42% | -$7.08M |
|
|
TBIO
83
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $8.8M | 0.27% |
+22,222
| New | +$7.86M |
|
84
GH Research
GHRS
$2B
| $8.69M | 0.27% |
+400,000
| New | +$8.17M |
|
|
ZY
85
DELISTED
Zymergen Inc. Common Stock
ZY
| $8.59M | 0.27% |
+214,577
| New | +$8.47M |
|
86
Alpha Teknova
TKNO
$378M
| $8.31M | 0.26% |
+350,000
| New | +$8.86M |
|
87
Seer Inc
SEER
$119M
| $8.29M | 0.26% |
253,041
-8,882
| -3% | -$350K |
|
88
Guardant Health
GH
$22.2B
| $8.23M | 0.26% |
66,240
-37,668
| -36% | -$5.07M |
|
89
Zimmer Biomet
ZBH
$18.5B
| $8.04M | 0.25% |
51,500
-50,416
| -49% | -$8.17M |
|
90
PUT
NovoCure
NVCR
$2.06B
| $7.7M | 0.24% |
+34,700
| New | +$6.75M |
|
91
CALL
AbbVie
ABBV
$442B
| $7.41M | 0.23% |
+65,800
| New | +$7.41M |
|
92
SkinHealth Systems
SKIN
$91.1M
| $7.39M | 0.23% |
+439,766
| New | +$6.01M |
|
93
Bionano Genomics
BNGO
$13.7M
| $7.33M | 0.23% |
1,667
| – | – |
|
|
CMPS
94
Compass Pathways
CMPS
$1.85B
| $7.25M | 0.23% |
190,071
+81,925
| +76% | +$2.93M |
|
95
CVRx
CVRX
$69.3M
| $7M | 0.22% |
+250,000
| New | +$7M |
|
96
PUT
Clover Health Investments
CLOV
$2.33B
| $6.66M | 0.21% |
+500,000
| New | +$4.91M |
|
97
PUT
ABM Industries
ABM
$2.83B
| $6.65M | 0.21% |
+150,000
| New | +$7.53M |
|
98
PUT
Quest Diagnostics
DGX
$26.2B
| $6.6M | 0.21% |
+50,000
| New | +$6.55M |
|
|
NSTG
99
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
| $6.48M | 0.2% |
+100,000
| New | +$6.35M |
|
|
MRTX
100
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $6.38M | 0.2% |
39,522
+9,280
| +31% | +$1.49M |
|
Similar funds
BCA
RC
DOFI
SCI
LPC
GBCP
SCTC
M
Pura Vida Investments's Q2 2021 Portfolio in Review
As of Q2 2021, Pura Vida Investments held 304 positions worth $3.21B, down 8.4% from $3.51B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Pura Vida Investments withdrew a net $592M in Q2 2021, closing 88 positions and reducing 82 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $23.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Industrials and Materials.
Against the trend, Pura Vida Investments opened a new position in AtaiBeckley Inc worth $23.2M.
- Pura Vida Investments's largest Q2 2021 buy was AtaiBeckley Inc: 1,371,824 shares worth $23.2M.
- Pura Vida Investments added most to Quotient Limited Ordinary Shares in Q2 2021, an estimated $9.15M increase.
- Pura Vida Investments's biggest Q2 2021 reduction was STAAR Surgical, cutting an estimated $14.6M.
- Pura Vida Investments fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $23.9M.
- Pura Vida Investments's ten largest holdings make up 43% of its $3.21B portfolio in Q2 2021.
- Pura Vida Investments opened 89 new positions and closed 88 in Q2 2021.
- Pura Vida Investments's portfolio value fell 8.4% quarter-over-quarter to $3.21B.
Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.